|
|
|
| The Correlation Analysis of Asymmetric Dimethylarginine (ADMA) Level and Phenylketonuria Control |
| ZUO Xuemei, et al |
| Chengde Maternal and Child Health Hospital, Hebei Chengde 067000, China |
|
|
|
|
Abstract Objective: To observe the correlation between the improvement of clinical symptoms and analyze the factors such as symmetric dimethylarginine and arginine by detecting the levels of asymmetric dimethylarginine and phenylalanine in the blood of children with phenylketonuria and to analyze the predictive value of the disease control in patients with phenylketonuria. Methods: Ninety-six children with PKU who were regularly reexamined in Chengde Maternal and Child Health Hospital from September 2016 to March 2019 were selected. The concentration of phenylalanine (Phe) in the blood was detected by high performance liquid chromatography. Patients were divided into a well-controlled group (Phe240~600μmol/L) and a poorly-controlled group (Phe>600μmol/L) considering the control level of phenylalanine; another 100 healthy children were selected and made the control group. The clinical data and laboratory indicators of the three groups of children were compared using high-performance liquid chromatography. The detection covers PHE, symmetric dimethylarginine(SDMA), asymmetric dimethylarginine (ADMA), arginine (ARG), total homocysteine (HCY). Automatic biochemical detector was used to detect serum creatinine (Serum creatinine, SCR) fine Amino acid (Arginine, ARG), triglyceride (TG), total cholesterol (Totalcholesterol, TC), etc., and the clinical symptoms and intelligence scores of children were recorded; the correlation between ADMA and Phe, intelligence scores and other indicators was analyzed; multifactorial logistic regression analysis of independent related factors affecting children's intelligence development was conducted. Results:Compared with the control group, the intelligence score, ADMA, SDMA, Arg, Hcy water of PKU children were significantly lower than the control group, with statistical differences (P<0.05); compared with the poorly controlled group, the ADMA, SDMA, ARG levels and intelligence scores of the well-controlled group were significantly increased, with statistical differences (P<0.05); DMA, SDMA, ARG and HCY were the main factors affecting the concentration of phenylalanine (P<0.05). Among them, ADMA, SDMA, and ARG were negatively correlated with phenylalanine concentration, and positively correlated with intelligence scores. The correlation coefficients were 0.6, 0.7, and 0.4, respectively. Multivariate logistic regression analysis shows that high PHE level (OR=1.952) is an independent related factor that affects intellectual development (P<0.05), while older age (OR=1.074) and high ADMA level (OR=1.556) are protective factors for children's intellectual development (P<0.05). Conclusion: ADMA can be used as an emerging indicator for evaluating dietary metabolism control in children with PKU, and can effectively predict children's intellectual development.
|
|
|
|
|
|
[1] 黄奎奎,郝胜菊,王兴,等.甘肃省2009年至2016年苯丙酮尿症筛查现况与发病趋势分析[J].中国优生与遗传杂志,2017,25(2):95~96.
[2] 秦玉兰,苏雅洁,李龙.苯丙酮尿症治疗研究新进展[J].国际儿科学杂志,2018,45(8):624~628.
[3] 牛瑞青,冯文化.苯丙酮尿症及相关治疗方法研究进展[J].中国新药杂志,2018,27(2):154~158.
[4] 韩宗兰,王兰英,王海楠,等.影响苯丙酮尿症患儿生活质量的相关因素及干预措施[J].中国医药导报,2019,16(6):90~93.
[5] Elizabeth Tinsley. Childhood disorders: Phenylketonuria[J]. MA Healthcare,2018,6(12):592~594.
[6] Geoffrey Y. Berguig,Nathan T. Martin,Athena Y. et al. Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain[J]. Molecular Genetics and Metabolism,2019,128(4):422~430.
[7] Fernando Andrade,Olatz Villate,Maria L. Couce,María A. et al. Asymmetric dimethylARGinine as a potential biomarker for management and follow-up of phenylketonuria[J]. European Journal of Pediatrics,2019,178(6):903~911.
[8] A. Bartus,F. Palasti,E. Juhasz,E.et al. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients[J]. Metabolic Brain Disease,2018,33(5):1609~1615.
[9] Alicia de la Parra,Maria Ignacia Garcia,Valerie Hamilton,et al. First-year metabolic control guidelines and their impact on future metabolic control and neurocognitive functioning in children with PKU[J]. Molecular Genetics and Metabolism Reports,2017,13:90~94.
[10] Gabriela Castro,Carolina Arias,Juan Francisco Cabello,et al. Follow up of children with classic PKU Diagnosed by newborn screening program in clile: 24 years of experience[J]. Annals of Nutrition & Metabolism,2017,71:1036. |
|
|
|
2021, Vol. 27 
